David Krantz

First-Trimester Screening for Trisomies 21 and 18

Ronald J. Wapner, Elizabeth Thom, Joe Leigh Simpson et al. · New England Journal of Medicine · 2003 · 567 citations · Full text

Association of extreme first-trimester free human chorionic gonadotropin-β, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes

David Krantz, Laura Goetzl, Joe Leigh Simpson et al. · American Journal of Obstetrics and Gynecology · 2004 · 285 citations

Nuchal Translucency, Developmental Biology, Fertility +13

Maternal serum Down syndrome screening: Free β-protein is a more effective marker than human chorionic gonadotropin

James N. Macri, Ramana V. Kasturi, David Krantz et al. · American Journal of Obstetrics and Gynecology · 1990 · 213 citations

Down Syndrome, Fertility, Human Chorionic Gonadotropin +13

First-Trimester down syndrome screening using dried blood biochemistry and nuchal translucency

David Krantz · Obstetrics and Gynecology · 2000 · 165 citations

Measurement of nasal bone length at 11–14 weeks of pregnancy and its potential role in Down syndrome risk assessment

F. Orlandi, C. M. Bilardo, M Campogrande et al. · Ultrasound in Obstetrics and Gynecology · 2003 · 120 citations · Full text